AICDs effective for symptoms, lethal arrhythmia in Brugada

January 10, 2018

(HealthDay)—Implantable cardioverter-defibrillators (ICDs) are effective in young patients with symptomatic Brugada syndrome, according to a study published in the Jan. 16 issue of the Journal of the American College of Cardiology.

M. Cecilia Gonzalez Corcia, M.D., from Universitair Ziekenhuis Brussel-Vrije Universiteit Brussel, and colleagues investigated clinical features, management, and long-term follow-up (mean, 88 months) of 35 young patients (mean age, 13.9 years) with Brugada syndrome who had an ICD implanted at an age of ≤20 years.

The researchers found that the vast majority of patients (92 percent) were symptomatic, including 29 percent presented with aborted and 63 percent with syncope. ICDs treated sustained in nine patients, including shocks in eight patients (23 percent) and antitachycardia pacing in one patient. An electrical storm caused death in three patients, while seven patients experienced inappropriate shocks and five patients had device-related complications. Independent predictors of appropriate occurrence were aborted sudden cardiac death and spontaneous type I electrocardiogram.

"ICD therapy is an effective strategy in young patients with symptomatic Brugada syndrome, treating potentially lethal arrhythmias in >25 percent of during follow-up," the authors write.

Explore further: Updated guidelines detail treatment for patients with ventricular arrhythmias

More information: Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Related Stories

Updated guidelines detail treatment for patients with ventricular arrhythmias

October 30, 2017
The American College of Cardiology, along with the American Heart Association and the Heart Rhythm Society, today published new guidelines for the treatment of patients with ventricular arrhythmias and the prevention of sudden ...

Similar complication rate for transvenous, subcutaneous ICDs

November 1, 2016
(HealthDay)—For patients at risk for sudden cardiac death, the rate of complications is similar with transvenous implantable cardioverter-defibrillators (TV-ICDs) and subcutaneous ICDs (S-ICDs), although the nature of complications ...

Follow-up testing indicated for inherited cardiac syndrome that can cause sudden death

November 16, 2014
Giulio Conte, M.D., of the Heart Rhythm Management Centre, UZ Brussel-VUB, Brussels, Belgium and colleagues investigated the clinical significance of repeat testing after puberty in asymptomatic children with a family history ...

Predictive models may help determine which patients benefit from ICDs

May 22, 2017
Two predictive models may help cardiologists decide which patients would most benefit from an implantable cardioverter defibrillator (ICD), suggests a new study published today in the Journal of the American College of Cardiology. ...

LVEF improvement for many with primary prevention ICDs

July 30, 2015
(HealthDay)—Forty percent of patients with primary prevention implantable cardioverter-defibrillators (ICDs) experience improvement in left ventricular ejection fraction (LVEF), according to a study published in the Aug. ...

Adding defibrillator to CRT no benefit in dilated cardiomyopathy

April 3, 2017
(HealthDay)—For patients with heart failure with indications for cardiac resynchronization therapy (CRT), those with ischemic cardiomyopathy (ICM), but not those with nonischemic dilated cardiomyopathy (DCM), benefit from ...

Recommended for you

Women at greater risk of stress-induced ischemia after heart attacks

April 24, 2018
Women who've previously experienced a heart attack have twice the risk of later myocardial ischemia provoked by mental stress when compared to men with a similar history, according to a study published in Circulation.

Electric cars don't jolt implanted heart devices: study

April 24, 2018
(HealthDay)—People who have implanted devices to keep their hearts running smoothly can safely drive an electric car if they wish to do so, new research confirms.

Hippo pathway found essential to orchestrate the development of the heart

April 23, 2018
Using a technology that provides a 'high-resolution view' of the status of individual cells, a team of researchers has gained new insights into the embryonic development of the mouse heart. They discovered that during development, ...

Compound improves stroke outcome by reducing lingering inflammation

April 20, 2018
An experimental compound appears to improve stroke outcome by reducing the destructive inflammation that can continue months after a stroke, scientists report.

Infections could trigger stroke in pregnant women during hospital delivery

April 20, 2018
Pregnant women who have an infection when they enter the hospital for delivery might be at higher risk of having a stroke during their stay, according to new research.

Novel antioxidant makes old blood vessels seem young again

April 19, 2018
Older adults who take a novel antioxidant that specifically targets cellular powerhouses, or mitochondria, see age-related vascular changes reverse by the equivalent of 15 to 20 years within six weeks, according to new University ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.